August 27, 2014 11:07 AM ET

Healthcare Providers and Services

Company Overview of Profarma Distribuidora de Produtos Farmacêuticos S.A.

Company Overview

Profarma Distribuidora de Produtos Farmacêuticos S.A. is engaged in the distribution, wholesale, and retail of pharmaceutical and hospital products in Brazil. The company operates through Pharmaceutical Distribution, Hospital & Special Medications, and Retail segments. It provides medicines, personal care, beauty, and dermatological products; and toiletries, vaccines, prostheses, and hormones in the South, Southeast, Northeast, and Center-West regions of Brazil through 12 distribution centers. The company also operates approximately 140 stores in the state of Rio de Janeiro. In addition, it provides information technology, cargo and transportation planning and control, and sales promotion an...

Avenida das Américas

nº 500, Bloco 12

sala 106

Grupo 205 à 208, Barra da Tijuca

Rio de Janeiro, RJ 22640-100

Brazil

Founded in 1961

Phone:

55 21 4009 0276

Fax:

55 21 2494 7333

Key Executives for Profarma Distribuidora de Produtos Farmacêuticos S.A.

Profarma Distribuidora de Produtos Farmacêuticos S.A. does not have any Key Executives recorded.

Profarma Distribuidora de Produtos Farmacêuticos S.A. Key Developments

Profarma Distribuidora de Produtos Farmacêuticos S.A. Announces Unaudited Consolidated and Parent Earnings Results for the Second Quarter Ended June 30, 2014; Announces Write of Fixed Assets/Intangibles for the Second Quarter of 2014

Profarma Distribuidora de Produtos Farmacêuticos S.A. announced unaudited consolidated and parent earnings results for the second quarter ended June 30, 2014. For the quarter, on consolidated basis, the company reported gross operating revenue was BRL 1,009,202,000 compared to BRL 1,016,927,000 for the same period a year ago. Net operating revenue was BRL 878,613,000 compared to BRL 880,046,000 for the same period a year ago. Operating income prior to financial results was BRL 6,241,000 compared to BRL 24,635,000 for the same period a year ago. Operating income was BRL 1,812,000 compared to BRL 13,127,000 for the same period a year ago. Net income before minority interests was BRL 2,141,000 compared to BRL 11,871,000 for the same period a year ago. Net income for the quarter was BRL 2,141,000 compared to BRL 12,640,000 for the same period a year ago. Net income per batch of 1,000 shares was BRL 52 compared to BRL 377 for the same period a year ago. Cash used in operating activities was BRL 11,898,000 compared to BRL 31,610,000 for the same period a year ago. Additions to fixed assets were BRL 4,064,000 compared to BRL 1,469,000 for the same period a year ago. Additions to intangible assets were BRL 831,000 compared to BRL 196,000 for the same period a year ago. EBITDA was BRL 20.4 million compared to BRL 33.1 million for the same period a year ago. Net debt was BRL 167.1 million compared to BRL 359.4 million at the same period a year ago. Adjusted net income was BRL 4.4 million compared to BRL 19.0 million for the same period a year ago. The consolidated data show a decrease in net income reflecting a rise of BRL 8.7 million in net financial expense directly connected with the company's higher debt, mainly due to the acquisitions of the Drogasmil/Farmalife and Tamoio drugstore chains in 2013. Net income was impacted by the 6% lower number of business days and the 22.2% lower price increase in second quarter of 2014. At their usual levels, these events would have impacted net income positively by about BRL 12.3 million. For the quarter, on parent company basis, the company reported gross operating revenue was BRL 877,280,000 compared to BRL 906,405,000 for the same period a year ago. Net operating revenue was BRL 760,765,000 compared to BRL 782,792,000 for the same period a year ago. Operating income prior to financial results was BRL 1,122,000 compared to BRL 23,048,000 for the same period a year ago. Operating income was BRL 2,573,000 compared to BRL 13,828,000 for the same period a year ago. Net income before minority interests was BRL 2,141,000 compared to BRL 12,640,000 for the same period a year ago. Net income for the quarter was BRL 2,141,000 compared to BRL 12,640,000 for the same period a year ago. Net income per batch of one thousand shares was BRL 52 compared to BRL 377 for the same period a year ago. Cash used in operating activities was BRL 12,253,000 compared to BRL 18,629,000 for the same period a year ago. Additions to fixed assets were BRL 1,116,000 compared to BRL 1,356,000 for the same period a year ago. Additions to intangible assets were BRL 136,000 compared to nil for the same period a year ago. Adjusted net loss was BRL 1.3 million compared to adjusted net income of BRL 2.1 million for the same period a year ago. On consolidated basis, for the quarter the company reported, write of fixed assets/intangible of BRL 113,000 compared to BRL 46,000 for the same period a year ago and on parent company basis write of fixed assets/intangible was BRL 98,000 compared to BRL 2,000 for the same period a year ago.

Profarma Distribuidora de Produtos Farmacêuticos S.A., Board Meeting, Aug 08, 2014

Profarma Distribuidora de Produtos Farmacêuticos S.A., Board Meeting, Aug 08, 2014.

AmerisourceBergen Corporation and Profarma Distribuidora de Produtos Farmacêuticos S.A. Form Joint Venture

AmerisourceBergen Corporation announced that Profarma Distribuidora de Produtos Farmacêuticos S.A. have launched a joint venture to provide enhanced specialty distribution and services to the Brazilian marketplace. The company has invested a total of approximately $110 million in an approximately 19.9% minority stake in Profarma, and a 50% stake in the specialty joint venture. The specialty joint venture will be led by Craig Miller, who will serve as the chief executive officer of the specialty joint venture, and who previously led AmerisourceBergen's US BioServices.

Similar Private Companies By Industry

Company Name Region
Casa de Saúde Santa Lúcia S.A Americas
Environ Cientifica Ltda. Americas
SEPAO Assistência Odontológica Empresarial Ltda. Americas
Applied Biosystems do Brasil Ltda. Americas
MD1 Diagnosticos S.A. Americas

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 20, 2014
Arp Med SA
Buyback
December 6, 2013
--
Merger/Acquisition
September 27, 2013
Prodiet Farmaceutica Ltda.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Profarma Distribuidora de Produtos Farmacêuticos S.A., please visit www.profarma.com.br. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.